IOL Chemicals and Pharmaceuticals is an API manufacturer based in India. It holds 16 active US drug master files and 21 valid CEPs across a filed portfolio of 18 molecules. Its GMP standing is certified by EMA and MFDS (Korea). Its most recent recorded inspection, by US FDA, closed on 9 August 2019 as VAI. Customs aggregates show $48.3M of exports covering 1,065 molecules to 83 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Ludhiana, India | Not on file |
| Ludhiana, India | Not on file |
| Barnala, India | 3008232281 |
| Barnala, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Ibuprofen | EDQM, SFDA (Saudi Arabia), US FDA | 6 |
| Clopidogrel | EDQM, US FDA | 3 |
| Lamotrigine | EDQM, US FDA | 3 |
| Metformin | EDQM, US FDA | 3 |
| Pantoprazole | EDQM, US FDA | 3 |
| Acetaminophen | EDQM, US FDA | 2 |
| Allopurinol | EDQM, US FDA | 2 |
| Fenofibrate | EDQM, US FDA | 2 |
| Levetiracetam | EDQM, US FDA | 2 |
| Losartan | EDQM, US FDA | 2 |
| Mesalazine | EDQM, US FDA | 2 |
| Quetiapine | EDQM, US FDA | 2 |
| Sitagliptin | EDQM, US FDA | 2 |
| Valsartan | EDQM, US FDA | 2 |
| Gabapentin | EDQM | 1 |
| Metformin Hydrochloride | EDQM | 1 |
| Minoxidil | EDQM | 1 |
| Pantoprazole Sodium Sesquihydrate | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 7 | None |
| EMA | None | 3 |
| MFDS (Korea) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $10.7M | 50 |
| 2025 | Not reported | $48.3M | 83 |
| 2024 | Not reported | $52.7M | 84 |
| 2023 | Not reported | $66.6M | 76 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. IOL Chemicals and Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free